S. Dewes

Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy

M. Schreckenberger, M. Bartholomä, S. Ezziddin, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy

M. Schreckenberger, M. Bartholomä, S. Ezziddin, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide

M. Bartholomä, A. Schaefer, S. Maus, 2020, European Journal of Nuclear Medicine and Molecular Imaging.